Access to palliative care and hospice reduces aggressive treatments among seriously ill patients that they neither desire nor benefit from.1, 2 However, these services—which focus on providing comfort, psychosocial support and symptom management—are frequently underutilized.1, 2 As the largest Awardee Convener in the Bundled Payments for Care Improvement (BPCI) initiative, Remedy Partners has developed a set of resources to advance the appropriate use of palliative care and hospice as this is a critically important aspect of care for patients experiencing acute or exacerbated chronic illness.
Lesli Ott Speaks: How Payers, Providers Improve Care and Increase Efficiencies with Bundles
Remedy Partners October 12, 2017
We sat down with Lesli Ott, Director of Episode Development for Remedy Partners’ Payer and Provider Solutions Group. Lesli leads a team of top analysts who collaborate with Remedy Partners’ clinical, technology and business teams to design and implement effective bundled payment programs for payers and providers. Here’s what she had to say about howpayers providers bundled payments payers and providers are driving better care and cost outcomes by implementing bundled payment strategies:
Remedy in the News
Remedy Partners Appoints Value-Based Healthcare Expert, Chip Howard, as Senior Vice President of Partner Services
Business Wire | October 5, 2017
Meet Chip Howard, SVP of Partner Services, Remedy Partners
Convergence | October 4, 2017
Chris Garcia Named CEO of Remedy Partners
Remedy Partners, the nation’s leading bundled payment company, has named Chris Garcia its chief executive officer, effective July 12, 2017. Remedy is well-positioned for accelerated growth as the healthcare industry continues to adopt bundled payments as a core value-based payment strategy.
Three of Remedy Partners’ thought leaders spoke at last week’s MACRA Summit in Washington, D.C. The conference was focused on educating physicians, policy makers and an array of healthcare executives on MACRA and implications of potential new regulations, as well as the associated payment model options that are designed to improve care and restrain cost growth. Participants displayed palpable energy and interest in sponsoring new forms of payment and clinical models to improve our healthcare system.
We sat down with Lesli Ott, Director of Episode Development for Remedy Partners’ Payer and Provider Solutions Group. Lesli leads a team of top analysts who collaborate with Remedy Partners’ clinical, technology and business teams to design and implement effective bundled payment programs for payers and providers. Here’s what she had to say about how payers and providers are driving better care and cost outcomes by implementing bundled payment strategies:
Accomplished healthcare leader brings valuable experience to Remedy Partners, furthering success for its partners under voluntary bundled payment arrangements
DARIEN, Conn.--(BUSINESS WIRE)--Remedy Partners, the nation’s leading bundled payment company, has hired Chip Howard as Senior Vice President, Partner Services. Howard brings with him 18 years of experience with leading payer organizations and is a key addition to the Remedy Partners leadership team.
The Remedy Partners Way: Networks, People, and Episode Tools Help Patients Recover at Home, Avoid Rehospitalization
We Must Do More to Help Our Most Vulnerable Seniors Recover With Dignity and Compassion
In my 30 years as a physical therapist, I have often been asked to review cases on behalf of my fellow practitioners. One recent case in particular tugged at my heartstrings because it exemplifies the damage that can be done when we fail to put patients at the center of care, and instead treat to payment incentives. This patient, whom I’ll call “Edna,” had been discharged to a skilled nursing facility (SNF) after a hip replacement to repair her fractured hip. Edna had exhausted the 100 days of skilled therapy covered under Medicare Part A. As she transitioned to hospice care on day 102, the orthopedic surgeon wanted to know what had gone wrong.
Medicare’s voluntary BPCI program’s financial results reveal positive NPRA for 100 percent of Remedy Partners’ engaged hospitals and 81 percent of its partner clients
DARIEN, Conn.--(BUSINESS WIRE)--Remedy Partners, the nation’s leading bundled payment company, shared the latest financial results achieved by its partners, revealing that 100 percent of the company’s hospital partners participating in Medicare’s voluntary bundled payment model exceeded the financial targets set by the Centers for Medicare and Medicaid Services (CMS). These results demonstrate the positive impact that care redesign and coordination are having on the outcomes of Medicare beneficiaries included in the Bundled Payments for Care Improvement (BPCI) program.
Addressing the tendency of fee-for-service to promote more spending requires changing the metrics that motivate clinician behavior away from volume as a primary focus. The DRG system, an early example of bundled payment, represents an attempt to solve the problem by paying hospitals a set amount for each hospitalization. DRG-based reimbursement incentivizes hospitals to keep costs down by eliminating unnecessary services and by shortening length of stay (LOS). Indeed, in the 30 years following the introduction of the DRG system, average hospital LOS nearly halved, dropping from 10.0 days in 1983 to 5.1 days in 20131,2.
Today, Seema Verma, the Centers for Medicare and Medicaid Services (CMS) Administrator, published a Request for Information seeking feedback on how to lead CMS’s Innovation Center in a new direction. Her statements reflect a belief in competition, consumer empowerment and a willingness to use waivers to enable meaningful innovation.
According to a Proposed Rule released on August 10, Medicare's next iteration of voluntary bundled payments will be an Advanced APM in 2018, opening the door for robust participation. The Proposed Rule, if implemented in January 2018, would cancel the Mandatory Cardiac Episode Payment Models and make participation voluntary in the Comprehensive Care for Joint Replacement model for half of selected Metropolitan Statistical Areas (MSAs) and for low-volume and rural hospitals.